Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes

Title
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
Authors
Keywords
Antibodies, HIV-1, Vaccination and immunization, Immune response, Vaccines, Rectum, Enzyme-linked immunoassays, Antibody response
Journal
PLoS One
Volume 8, Issue 2, Pages e55438
Publisher
Public Library of Science (PLoS)
Online
2013-02-21
DOI
10.1371/journal.pone.0055438

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More